InnoCare Pharma Limited

HK$12.10As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9969Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR 0.93%
Div yield —
ROE 18.34%
Biotechnology
Beta (5Y) 0.45
PE TTM 13.49
TSR TTM (15.09%)
Mkt cap HK$25.69B
ROIC 40.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$12
0.34%
87.97%
Hold 1|10|12|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.24
0.26
0.28
0.29
18.86%
32.53%
33.69%
29.42%
Revenue¥B
2.844
2.865
2.929
2.994
(3.35%)
(5.49%)
(1.77%)
3.00%
Peers (US$3.277B)
Cap (US$)
PE
2.865B
—
3.268B
—
Capital
TTM
5Y
10Y
Leveragex
1.640
4.460
3.295
EBIT/Intx
0.188
0.066
0.055
Own earn%
(58.36)
(88.78)
(70.38)
Sh yield%
8.72
42.62
41.02
Owners
Insiders/Inst%
9.41
32.34
Short interest%
5.93
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
29–36
$1 testx
—
Incr. ROIC%
2